PMMA: Difference between revisions
>Dextromethorphan |
>Myriadis m Added legal status in France |
||
(52 intermediate revisions by 14 users not shown) | |||
Line 1: | Line 1: | ||
{{headerpanel|{{Template:Warning/PMMA}} | {{headerpanel|{{Template:Warning/PMMA}}}} | ||
{{SummarySheet}} | |||
{{SubstanceBox/PMMA}} | {{SubstanceBox/PMMA}} | ||
'''para-Methoxymethamphetamine''' (also known as '''4-methoxymethamphetamine''', '''4-MeOMA''', inaccurately as '''"4-MMA"''' (which should instead be reserved for [[4-MMA]] (4-MeMA) instead) and more commonly as '''PMMA''') is a highly dangerous and toxic synthetic substance of the [[Chemical class::amphetamine]] class that is closely related to [[PMA]]. Like PMA, it is known for producing extremely dangerous, life-threatening side effects. At lower dosages, its effects are somewhat different from PMA, with reduced tendency to cause severe [[Increased bodily temperature|hyperthermia]] while producing more [[entactogenic]] effects that can be mistaken for [[MDMA]] (although at higher dosages it does have the same risk as PMA). Its history of use is unknown, but it has appeared more frequently in the 2000s and 2010s. It is generally less potent than PMA. | |||
'''PMMA, along with other drugs like [[PMA]] and [[PMEA]] have very little recreational value and are considered as one of the most dangerous and toxic substances known. It is strongly recommended that these two substances should be completely avoided.''' | |||
''' | |||
==Chemistry== | ==Chemistry== | ||
PMMA (para-Methoxymethamphetamine or 4-MMA) is a molecule of the [[substituted | PMMA (para-Methoxymethamphetamine or 4-MMA) is a molecule of the [[substituted amphetamine]] class. Molecules of the amphetamine class contain a phenethylamine core featuring a phenyl ring bound to an amino (NH<sub>2</sub>) group through an ethyl chain with an additional methyl substitution at R<sub>α</sub>. It contains a methoxy (OCH<sub>3</sub>) functional group bound to the R<sub>4</sub> carbon of the phenyl ring, as well as a methyl substitution at R<sub>N</sub>. PMMA is the N-methylated version of [[PMA]] and the 4-Methoxy analog of [[Methamphetamine]]. | ||
==Pharmacology== | ==Pharmacology== | ||
Line 20: | Line 19: | ||
==Subjective effects== | ==Subjective effects== | ||
{{effectStub}} | {{effectStub}} | ||
{{Preamble/SubjectiveEffects}} | |||
{{effects/base | |||
|{{effects/physical| | |||
*'''[[Effect::Stimulation]]''' - In terms of its effects on the user's physical energy levels, PMMA is commonly regarded as moderately stimulating and energetic exclusively at lower dosages. | *'''[[Effect::Stimulation]]''' - In terms of its effects on the user's physical energy levels, PMMA is commonly regarded as moderately stimulating and energetic exclusively at lower dosages. | ||
*'''[[Effect::Abnormal heartbeat]]''' | *'''[[Effect::Abnormal heartbeat]]''' - Accelerated and abnormal heartbeats are extremely common with PMMA. | ||
*'''[[Effect::Appetite suppression]]''' | *'''[[Effect::Appetite suppression]]''' | ||
*'''[[Effect::Dehydration]]''' | *'''[[Effect::Dehydration]]''' | ||
Line 32: | Line 32: | ||
*'''[[Effect::Increased heart rate]]''' | *'''[[Effect::Increased heart rate]]''' | ||
*'''[[Effect::Increased perspiration]]''' | *'''[[Effect::Increased perspiration]]''' | ||
*'''[[Effect::Nausea]]''' and ''' | *'''[[Effect::Nausea]]''' and '''Vomiting''' - This is common at any dose. | ||
*'''[[Effect::Pupil dilation]]''' | *'''[[Effect::Pupil dilation]]''' | ||
*'''[[Effect::Rapid breathing]]''' - People commonly report "not being able to breathe". | *'''[[Effect::Rapid breathing]]''' - People commonly report "not being able to breathe". | ||
Line 39: | Line 39: | ||
*'''[[Effect::Temporary erectile dysfunction]]''' | *'''[[Effect::Temporary erectile dysfunction]]''' | ||
*'''[[Effect::Vasoconstriction]]''' | *'''[[Effect::Vasoconstriction]]''' | ||
*'''[[Effect::Vibrating vision]]''' | *'''[[Effect::Vibrating vision]]''' - This effect is generally more frequent than with [[MDMA]]. | ||
}} | |||
|{{effects/cognitive| | |||
*'''[[Effect::Anxiety]]''' or '''[[Effect::Anxiety suppression]]''' - This depends greatly on the dosage, as higher dosages are almost guaranteed to bring anxiety, due to all the adverse effects. | *'''[[Effect::Anxiety]]''' or '''[[Effect::Anxiety suppression]]''' - This depends greatly on the dosage, as higher dosages are almost guaranteed to bring anxiety, due to all the adverse effects. | ||
*'''[[Effect::Empathy, love and sociability enhancement]]''' - This effect is only present at lower doses and its much less pronounced than with [[MDMA]]. | |||
*'''[[Effect::Cognitive euphoria]]''' or '''[[Effect::Cognitive dysphoria]]''' - This depends greatly on the dosage, as higher dosages are almost guaranteed to bring dysphoria, due to all the adverse effects. | *'''[[Effect::Cognitive euphoria]]''' or '''[[Effect::Cognitive dysphoria]]''' - This depends greatly on the dosage, as higher dosages are almost guaranteed to bring dysphoria, due to all the adverse effects. | ||
*'''[[Effect::Dream suppression]]''' | *'''[[Effect::Dream suppression]]''' | ||
*'''[[Effect::Time distortion]]''' | *'''[[Effect::Time distortion]]''' | ||
*'''[[Effect::Wakefulness]]''' | *'''[[Effect::Wakefulness]]''' | ||
}} | |||
{{effects/visual| | |||
At moderate to high dosages, PMMA is capable of producing typically mild or moderate visual distortions, which are usually more common and pronounced than with [[MDMA]], but significantly less when compared with most [[psychedelics]], such as [[2C-B]] or [[LSD]]. | At moderate to high dosages, PMMA is capable of producing typically mild or moderate visual distortions, which are usually more common and pronounced than with [[MDMA]], but significantly less when compared with most [[psychedelics]], such as [[2C-B]] or [[LSD]]. | ||
Line 57: | Line 61: | ||
====Distortions==== | ====Distortions==== | ||
*'''[[Effect::Visual drifting|Drifting]]''' ''([[Visual drifting#Melting|melting]], [[Visual drifting#Breathing|breathing]], [[Visual drifting#Morphing|morphing]] and [[Visual drifting#Flowing|flowing]])'' - This effects is more pronounced than [[MDMA]]. | *'''[[Effect::Visual drifting|Drifting]]''' ''([[Visual drifting#Melting|melting]], [[Visual drifting#Breathing|breathing]], [[Visual drifting#Morphing|morphing]] and [[Visual drifting#Flowing|flowing]])'' - This effects is more pronounced than it is with [[MDMA]]. | ||
*'''[[Effect::Tracers]]''' | *'''[[Effect::Tracers]]''' | ||
* | }} | ||
}} | |||
===Experience reports=== | |||
There are currently no anecdotal reports which describe the effects of this compound within our [[experience index]]. Additional experience reports can be found here: | |||
*[https://www.erowid.org/experiences/subs/exp_PMMA.shtml Erowid Experience Vaults: PMMA] | |||
==Toxicity and harm potential== | ==Toxicity and harm potential== | ||
Line 65: | Line 75: | ||
PMMA and its relative [[PMA]] [[Toxicity::can be considered extremely toxic when compared to other substances such as [[Methamphetamine]] or [[MDMA]] ]]. [[Toxicity::Ingestion of PMMA has been associated with severe tachycardia (abnormally high heart rate), [[seizure |seizures]], [[dehydration]], [[increased bodily temperature|hyperthermia]], and death]]. PMMA has a relatively slow onset, causing many users to redose which causes excess toxicity. | PMMA and its relative [[PMA]] [[Toxicity::can be considered extremely toxic when compared to other substances such as [[Methamphetamine]] or [[MDMA]] ]]. [[Toxicity::Ingestion of PMMA has been associated with severe tachycardia (abnormally high heart rate), [[seizure |seizures]], [[dehydration]], [[increased bodily temperature|hyperthermia]], and death]]. PMMA has a relatively slow onset, causing many users to redose which causes excess toxicity. | ||
It is strongly recommended that one use [[ | It is strongly recommended that one use [[harm reduction practices]] if choosing to use this substance. | ||
==Legal | ==Legal status== | ||
*'''Canada | In February 2002, the European Council decided that PMMA shall be subjected by the Member States to control measures and criminal penalties within three months.<ref>{{cite magazine|url=http://eur-lex.europa.eu/LexUriServ/LexUriServ.do?uri=OJ:L:2002:063:0014:0014:EN:PDF|date=February 28, 2002|publication-date=March 6, 2003|work=Official Journal of the European Union|page=14|id=L 63|publisher=Office for Official Publications of the European Communites|oclc=52224955|title=Council Decision concerning control measures and criminal sanctions in respect of the new synthetic drug PMMA}}</ref> | ||
*'''Germany | |||
*''' | *'''Austria''': PMMA is illegal to possess, produce and sell under the SMG (Suchtmittelgesetz Österreich).{{citation needed}} | ||
*'''United Kingdom | *'''Brazil''': Possession, production and sale is illegal as it is listed on Portaria SVS/MS nº 344.<ref>http://portal.anvisa.gov.br/documents/10181/3115436/%281%29RDC_130_2016_.pdf/fc7ea407-3ff5-4fc1-bcfe-2f37504d28b7</ref> | ||
*'''Canada''': PMMA is a Schedule I substance.{{citation needed}} | |||
*'''France''': PMMA is scheduled as a "stupéfiant", i.e. a recognized drug of abuse. It is illegal to possess, buy, sell or manufacture.<ref>{{Citation | title=Arrêté du 22 février 1990 fixant la liste des substances classées comme stupéfiants | url=https://www.legifrance.gouv.fr/loda/id/JORFTEXT000000533085/2020-11-20/}}</ref> | |||
*'''Germany''': PMMA is controlled under Anlage I BtMG (Narcotics Act, Schedule I) as of October 10, 2000.<ref>{{cite web|url=https://www.bgbl.de/xaver/bgbl/start.xav?start=%2F%2F*%5B%40attr_id%3D%27bgbl100s1414b.pdf%27%5D#__bgbl__%2F%2F*%5B%40attr_id%3D%27bgbl100s1414b.pdf%27%5D__1576702069328|title=Vierzehnte Verordnung zur Änderung betäubungsmittelrechtlicher Vorschriften|publisher=Bundesanzeiger Verlag|access-date=December 18, 2019|language=de}}</ref><ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/anlage_i.html|title=Anlage I BtMG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref> It is illegal to manufacture, possess, import, export, buy, sell, procure or dispense it without a license.<ref>{{cite web|url=https://www.gesetze-im-internet.de/btmg_1981/__29.html|title=§ 29 BtMG|publisher=Bundesministerium der Justiz und für Verbraucherschutz|access-date=December 18, 2019|language=de}}</ref> | |||
*'''Switzerland''': PMMA is a controlled substance specifically named under Verzeichnis D.<ref>{{cite web|url=https://www.admin.ch/opc/de/classified-compilation/20101220/index.html|title=Verordnung des EDI über die Verzeichnisse der Betäubungsmittel, psychotropen Stoffe, Vorläuferstoffe und Hilfschemikalien|publisher=Bundeskanzlei [Federal Chancellery of Switzerland]|access-date=January 1, 2020|language=de}}</ref> | |||
*'''United Kingdom''': PMMA is a Class A drug.{{citation needed}} | |||
*'''United States''': PMMA is a Schedule I drug as of July 26th, 2021.<ref>https://www.federalregister.gov/documents/2021/06/25/2021-13460/schedules-of-controlled-substances-placement-of-para-methoxymethamphetamine-pmma-in-schedule-i</ref> | |||
==See also== | ==See also== | ||
*[[Responsible use]] | *[[Responsible use]] | ||
*[[Research chemical]] | |||
*[[Substituted amphetamine]] | *[[Substituted amphetamine]] | ||
*[[Entactogen]] | *[[Entactogen]] | ||
*[[PMA]] | *[[PMA]] | ||
==External links== | |||
*[https://en.wikipedia.org/wiki/Para-Methoxy-N-methylamphetamine PMMA (Wikipedia)] | |||
*[https://www.erowid.org/chemicals/pmma/pmma.shtml PMMA (Erowid Vault)] | |||
*[https://isomerdesign.com/PiHKAL/read.php?domain=pk&id=130 PMMA (PiHKAL / Isomer Design)] | |||
==References== | ==References== | ||
<references/> | {{references}} | ||
<references /> | |||
[[Category:Proofread]] | [[Category:Proofread]] | ||
[[Category:Psychoactive substance]] | |||
[[Category:Research chemical]] | |||
[[Category:Amphetamine]] | |||
[[Category:Entactogen]] | |||
{{#set:Featured=false}} |